Pay in 4 interest-free payments of $5.69 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Trimetazidine is being assessed for its efficacy in treating bipolar depression in an international multi-site clinical trial (Australian New Zealand Clinical Trials Registry registration: ACTRN12622000474752)
Vials were intact, properly cushioned, and nothing shifted in transit
doi: 10.1016/S1474-4422(07)70327-7 43
Clinical and molecular characterization of 6 children with glutamatecysteine ligase deficiency causing hemolytic anemia
US$ 28.59
US$ 25.37
US$ 29.84
US$ 21.24
US$ 21.15
